UiPath Stock Surges Past Analyst Target: What’s Next?
In recent trading, shares of UiPath Inc (Symbol: PATH) have crossed above the average analyst 12-month target price of $15.33, currently trading at $15.50 per share. When a stock reaches the target set by analysts, they typically have two options: downgrade based on valuation or adjust their target price upward. The response may vary depending on recent business developments that could be propelling the stock higher.
Analyst Target Overview
There are 15 different analyst targets within the Zacks coverage universe contributing to that average for UiPath Inc. However, averages can be misleading. One analyst has set a target as low as $12.00, while another sees the stock potentially rising to $19.00. The standard deviation among these targets stands at $1.799.
Wisdom of the Crowd
The significance of the average PATH price target lies in its representation of collective analyst insights. With the stock trading above the average target price of $15.33 per share, it calls for investors to reassess the company. Is this price merely a stepping stone toward a much higher target, or has the stock become overvalued, suggesting it might be time to reduce holdings?
Recent PATH Analyst Ratings Breakdown | ||||
---|---|---|---|---|
» | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
Strong buy ratings: | 2 | 2 | 2 | 2 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 18 | 18 | 18 | 18 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 2.8 | 2.8 | 2.8 | 2.8 |
The average rating is based on a scale of 1 to 5, where 1 represents Strong Buy and 5 signifies Strong Sell. This article references data provided by Zacks Investment Research via Quandl.com.
The Top 25 Broker Analyst Picks of the S&P 500 »
Also see:
• EZJ shares outstanding history
• ETFs Holding MPWR
• PPTA shares outstanding history
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.